The role of the microbiota-gut-brain axis in neuropsychiatric disorders

Revista Brasileira de Psiquiatria - Tập 43 Số 3 - Trang 293-305
Jaqueline S. Generoso1, Vijayasree V. Giridharan2, June‐Young Lee3, Danielle Macêdo4, Tatiana Barichello5
1Laboratorio de Fisiopatologia Experimental, Programa de Pos-Graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense (UNESC), Criciuma, SC, Brazil
2Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA
3Department of Neurology, McGovern Medical School, UTHealth, Houston, TX, USA
4Laboratorio de Neuropsicofarmacologia, Nucleo de Pesquisa e Desenvolvimento de Medicamentos, Faculdade de Medicina, Universidade Federal do Ceara (UFC), Fortaleza, CE, BrazilInstituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCT-TM), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Ribeirao Preto, SP, Brazil
5Laboratorio de Fisiopatologia Experimental, Programa de Pos-Graduacao em Ciencias da Saude, Universidade do Extremo Sul Catarinense (UNESC), Criciuma, SC, BrazilFaillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Turner JR, 2009, Intestinal mucosal barrier function in health and disease, Nat Rev Immunol, 9, 799, 10.1038/nri2653

Gallo RL, 2012, Epithelial antimicrobial defence of the skin and intestine, Nat Rev Immunol, 12, 503, 10.1038/nri3228

Rogers GB, 2016, From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways, Mol Psychiatry, 21, 738, 10.1038/mp.2016.50

Neufeld KM, 2011, Reduced anxiety-like behavior and central neurochemical change in germ-free mice, Neurogastroenterol Motil, 23, 255, 10.1111/j.1365-2982.2010.01620.x

Sethi R, 2019, Neurobiology and therapeutic potential of cyclooxygenase-2 (COX-2) inhibitors for inflammation in neuropsychiatric disorders, Front Psychiatry, 10, 605, 10.3389/fpsyt.2019.00605

Modabbernia A, 2013, Cytokine alterations in bipolar disorder: a meta-analysis of 30 studies, Biol Psychiatry, 74, 15, 10.1016/j.biopsych.2013.01.007

Inoshita M, 2016, A significant causal association between C-reactive protein levels and schizophrenia, Sci Rep, 6, 26105, 10.1038/srep26105

Köhler CA, 2017, Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies, Acta Psychiatr Scand, 135, 373, 10.1111/acps.12698

Nishino R, 2013, Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods, Neurogastroenterol Motil, 25, 521, 10.1111/nmo.12110

Huo R, 2017, Microbiota modulate anxiety-like behavior and endocrine abnormalities in hypothalamic-pituitary-adrenal axis, Front Cell Infect Microbiol, 7, 489, 10.3389/fcimb.2017.00489

Bercik P, 2011, The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice., Gastroenterology, 141, 599, 10.1053/j.gastro.2011.04.052

Bravo JA, 2011, Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve, Proc Natl Acad Sci U S A, 108, 16050, 10.1073/pnas.1102999108

Thabane M, 2010, An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children, Am J Gastroenterol, 105, 933, 10.1038/ajg.2010.74

Lyte M, 1998, Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation, Physiol Behav, 65, 63, 10.1016/S0031-9384(98)00145-0

Gaykema RP, 2004, Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry, Brain Behav Immun, 18, 238, 10.1016/j.bbi.2003.08.002

Verdu EF, 2008, The role of luminal factors in the recovery of gastric function and behavioral changes after chronic Helicobacter pylori infection, Am J Physiol Gastrointest Liver Physiol, 295, G664, 10.1152/ajpgi.90316.2008

Champagne-Jorgensen K, 2020, Prenatal low-dose penicillin results in long-term sex-specific changes to murine behaviour, immune regulation, and gut microbiota, Brain Behav Immun, 84, 154, 10.1016/j.bbi.2019.11.020

Cryan JF, 2019, The microbiota-gut-brain axis, Physiol Rev, 99, 1877, 10.1152/physrev.00018.2018

Yu Y, 2019, The role of the gut microbiota in lipid and lipoprotein metabolism., J Clin Med, 8, E2227, 10.3390/jcm8122227

Koh A, 2016, From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites, Cell, 165, 1332, 10.1016/j.cell.2016.05.041

Krishnan S, 2018, Gut microbiota-derived tryptophan metabolites modulate inflammatory response in hepatocytes and macrophages, Cell Rep, 23, 1099, 10.1016/j.celrep.2018.03.109

Erny D, 2015, Host microbiota constantly control maturation and function of microglia in the CNS, Nat Neurosci, 18, 965, 10.1038/nn.4030

Louis P, 2014, The gut microbiota, bacterial metabolites and colorectal cancer, Nat Rev Microbiol, 12, 661, 10.1038/nrmicro3344

Morkl S, 2018, Gut microbiota, dietary intakes and intestinal permeability reflected by serum zonulin in women, Eur J Nutr, 57, 2985, 10.1007/s00394-018-1784-0

Chen T, 2019, Butyrate suppresses demyelination and enhances remyelination, J Neuroinflammation, 16, 165, 10.1186/s12974-019-1552-y

Agus A, 2018, Gut microbiota regulation of tryptophan metabolism in health and disease, Cell Host Microbe, 23, 716, 10.1016/j.chom.2018.05.003

Lamas B, 2016, CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands, Nat Med, 22, 598, 10.1038/nm.4102

Zelante T, 2013, Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22, Immunity, 39, 372, 10.1016/j.immuni.2013.08.003

Rooks MG, 2016, Gut microbiota, metabolites and host immunity, Nat Rev Immunol, 16, 341, 10.1038/nri.2016.42

Karbownik M, 2001, Indole-3-propionic acid, a melatonin-related molecule, protects hepatic microsomal membranes from iron-induced oxidative damage: relevance to cancer reduction, J Cell Biochem, 81, 507, 10.1002/1097-4644(20010601)81:3<507::AID-JCB1064>3.0.CO;2-M

Chyan YJ, 1999, Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid, J Biol Chem, 274, 21937, 10.1074/jbc.274.31.21937

de Mello VD, 2017, Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study, Sci Rep, 7, 46337, 10.1038/srep46337

Gao J, 2018, Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism, Front Cell Infect Microbiol, 8, 13, 10.3389/fcimb.2018.00013

Gibson GR, 2017, Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics, Nat Rev Gastroenterol Hepatol, 14, 491, 10.1038/nrgastro.2017.75

Burokas A, 2017, Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice, Biol Psychiatry, 82, 472, 10.1016/j.biopsych.2016.12.031

Savignac HM, 2013, Prebiotic feeding elevates central brain derived neurotrophic factor, N-methyl-D-aspartate receptor subunits and D-serine, Neurochem Int, 63, 756, 10.1016/j.neuint.2013.10.006

Baxter NT, 2019, Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers., mBio, 10, e02566-18, 10.1128/mBio.02566-18

Grimaldi R, 2018, A prebiotic intervention study in children with autism spectrum disorders (ASDs), Microbiome, 6, 133, 10.1186/s40168-018-0523-3

Azpiroz F, 2017, Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study., Neurogastroenterol Motil., 29

2006

Hill C, 2014, Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic, Nat Rev Gastroenterol Hepatol, 11, 506, 10.1038/nrgastro.2014.66

Desbonnet L, 2010, Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression, Neuroscience, 170, 1179, 10.1016/j.neuroscience.2010.08.005

Messaoudi M, 2011, Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects, Br J Nutr, 105, 755, 10.1017/S0007114510004319

Allen AP, 2016, Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers, Transl Psychiatry, 6, e939, 10.1038/tp.2016.191

Flint HJ, 2012, The role of the gut microbiota in nutrition and health, Nat Rev Gastroenterol Hepatol, 9, 577, 10.1038/nrgastro.2012.156

Samuel BS, 2008, Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41, Proc Natl Acad Sci U S A, 105, 16767, 10.1073/pnas.0808567105

Braniste V, 2014, The gut microbiota influences blood-brain barrier permeability in mice, Sci Transl Med, 6, 263ra158, 10.1126/scitranslmed.3009759

Yoo DY, 2011, Synergistic effects of sodium butyrate, a histone deacetylase inhibitor, on increase of neurogenesis induced by pyridoxine and increase of neural proliferation in the mouse dentate gyrus, Neurochem Res, 36, 1850, 10.1007/s11064-011-0503-5

Kim HJ, 2009, The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain, J Neurochem, 110, 1226, 10.1111/j.1471-4159.2009.06212.x

Gutierrez-Vazquez C, 2018, Regulation of the immune response by the aryl hydrocarbon receptor, Immunity, 48, 19, 10.1016/j.immuni.2017.12.012

Rothhammer V, 2016, Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor, Nat Med, 22, 586, 10.1038/nm.4106

Dokalis N, 2019, Resolution of neuroinflammation: mechanisms and potential therapeutic option, Semin Immunopathol, 41, 699, 10.1007/s00281-019-00764-1

Muku GE, 2018, Urolithin a is a dietary microbiota-derived human aryl hydrocarbon receptor antagonist., Metabolites, 8, E86, 10.3390/metabo8040086

Bonaz B, 2018, The vagus nerve at the interface of the microbiota-gut-brain axis, Front Neurosci, 12, 49, 10.3389/fnins.2018.00049

Bogunovic M, 2007, Enteroendocrine cells express functional Toll-like receptors, Am J Physiol Gastrointest Liver Physiol, 292, G1770, 10.1152/ajpgi.00249.2006

Liu B, 2017, Vagotomy and Parkinson disease: a Swedish register-based matched-cohort study, Neurology, 88, 1996, 10.1212/WNL.0000000000003961

Mitchell AM, 2010, Streptococcus pneumoniae: virulence factors and variation, Clin Microbiol Infect, 16, 411, 10.1111/j.1469-0691.2010.03183.x

Kim KS, 2012, Current concepts on the pathogenesis of Escherichia coli meningitis: implications for therapy and prevention, Curr Opin Infect Dis, 25, 273, 10.1097/QCO.0b013e3283521eb0

Barichello T, 2013, Pathophysiology of neonatal acute bacterial meningitis, J Med Microbiol, 62, 1781, 10.1099/jmm.0.059840-0

Kumar S, 2013, Recognition of bacterial infection by innate immune sensors, Crit Rev Microbiol, 39, 229, 10.3109/1040841X.2012.706249

Heckenberg SG, 2014, Bacterial meningitis, Handb Clin Neurol, 121, 1361, 10.1016/B978-0-7020-4088-7.00093-6

Sellner J, 2010, Pathogenesis and pathophysiology of bacterial CNS infections, v. 96, 1

Mook-Kanamori BB, 2011, Pathogenesis and pathophysiology of pneumococcal meningitis, Clin Microbiol Rev, 24, 557, 10.1128/CMR.00008-11

Iwasaki A, 2010, Regulation of adaptive immunity by the innate immune system, Science, 327, 291, 10.1126/science.1183021

Abdel-Haq R, 2019, Microbiome-microglia connections via the gut-brain axis, J Exp Med, 216, 41, 10.1084/jem.20180794

Rodrigues FT, 2018, Major depression model induced by repeated and intermittent lipopolysaccharide administration: long-lasting behavioral, neuroimmune and neuroprogressive alterations, J Psychiatr Res, 107, 57, 10.1016/j.jpsychires.2018.10.003

Gu M, 2018, Endogenous omega (n)-3 fatty acids in fat-1 mice attenuated depression-like behavior, imbalance between microglial M1 and M2 phenotypes, and dysfunction of neurotrophins induced by lipopolysaccharide administration., Nutrients, 10, E1351, 10.3390/nu10101351

Simoes LR, 2018, Maternal immune activation induced by lipopolysaccharide triggers immune response in pregnant mother and fetus, and induces behavioral impairment in adult rats, J Psychiatr Res, 100, 71, 10.1016/j.jpsychires.2018.02.007

Dickerson F, 2017, The association between immune markers and recent suicide attempts in patients with serious mental illness: a pilot study, Psychiatry Res, 255, 8, 10.1016/j.psychres.2017.05.005

Zhao Y, 2017, Secretory products of the human GI tract microbiome and their potential impact on Alzheimer's disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus, Front Cell Infect Microbiol, 7, 318, 10.3389/fcimb.2017.00318

Pietrucci D, 2019, Dysbiosis of gut microbiota in a selected population of Parkinson's patients, Parkinsonism Relat Disord, 65, 124, 10.1016/j.parkreldis.2019.06.003

Schubert KO, 2015, Proteomic pathway analysis of the hippocampus in schizophrenia and bipolar affective disorder implicates 14-3-3 signaling, aryl hydrocarbon receptor signaling, and glucose metabolism: potential roles in GABAergic interneuron pathology, Schizophr Res, 167, 64, 10.1016/j.schres.2015.02.002

Fujisawa TX, 2016, Association of aryl hydrocarbon receptor-related gene variants with the severity of autism spectrum disorders, Front Psychiatry, 7, 184, 10.3389/fpsyt.2016.00184

Stilling RM, 2016, The neuropharmacology of butyrate: the bread and butter of the microbiota-gut-brain axis?, Neurochem Int, 99, 110, 10.1016/j.neuint.2016.06.011

Fischer A, 2007, Recovery of learning and memory is associated with chromatin remodelling, Nature, 447, 178, 10.1038/nature05772

Chandrasekar V, 2010, The brain-specific neural zinc finger transcription factor 2b (NZF-2b/7ZFMyt1) suppresses cocaine self-administration in rats, Front Behav Neurosci, 4, 14

Moretti M, 2011, Behavioral and neurochemical effects of sodium butyrate in an animal model of mania, Behav Pharmacol, 22, 766, 10.1097/FBP.0b013e32834d0f1b

Wei Y, 2014, Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene., Int J Neuropsychopharmacol., 18, pyu032

Takuma K, 2014, Chronic treatment with valproic acid or sodium butyrate attenuates novel object recognition deficits and hippocampal dendritic spine loss in a mouse model of autism, Pharmacol Biochem Behav, 126, 43, 10.1016/j.pbb.2014.08.013

Kazemi A, 2019, Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder:aA randomized clinical trial, Clin Nutr, 38, 522, 10.1016/j.clnu.2018.04.010

Liu YW, 2019, Effects of Lactobacillus plantarum PS128 on children with autism spectrum disorder in Taiwan: a randomized, double-blind, placebo-controlled trial., Nutrients., 11(4), E820, 10.3390/nu11040820

Reininghaus EZ, 2020, Probiotic treatment in individuals with euthymic bipolar disorder: a pilot-study on clinical changes and compliance, Neuropsychobiology, 79, 71, 10.1159/000493867

Severance EG, 2017, Probiotic normalization of Candida albicans in schizophrenia: a randomized, placebo-controlled, longitudinal pilot study, Brain Behav Immun, 62, 41, 10.1016/j.bbi.2016.11.019

Tamtaji OR, 2019, Probiotic and selenium co-supplementation, and the effects on clinical, metabolic and genetic status in Alzheimer's disease: a randomized, double-blind, controlled trial, Clin Nutr, 38, 2569, 10.1016/j.clnu.2018.11.034

Tamtaji OR, 2019, Clinical and metabolic response to probiotic administration in people with Parkinson's disease: a randomized, double-blind, placebo-controlled trial, Clin Nutr, 38, 1031, 10.1016/j.clnu.2018.05.018

Tankou SK, 2018, Investigation of probiotics in multiple sclerosis, Mult Scler, 24, 58, 10.1177/1352458517737390

Zhao H, 2017, The effect of fecal microbiota transplantation on a child with Tourette syndrome, Case Rep Med, 2017, 6165239, 10.1155/2017/6165239

Cai T, 2019, Fecal microbiota transplantation in an elderly patient with mental depression, Int Psychogeriatr, 31, 1525, 10.1017/S1041610219000115

Kang DW, 2017, Microbiota transfer therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study, Microbiome, 5, 10, 10.1186/s40168-016-0225-7

Kang DW, 2019, Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota, Sci Rep, 9, 5821, 10.1038/s41598-019-42183-0

Serrano-Pozo A, 2010, Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology, Brain, 133, 1312, 10.1093/brain/awq056

Torres L, 2018, Toxoplasma gondii alters NMDAR signaling and induces signs of Alzheimer's disease in wild-type, C57BL/6 mice, J Neuroinflammation, 15, 57, 10.1186/s12974-018-1086-8

Kumar DK, 2016, Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease, Sci Transl Med, 8, 340ra72, 10.1126/scitranslmed.aaf1059

Hill JM, 2014, Pathogenic microbes, the microbiome, and Alzheimer's disease (AD), Front Aging Neurosci, 6, 127

Giridharan VV, 2019, Infection-induced systemic inflammation is a potential driver of Alzheimer's disease progression, Front Aging Neurosci, 11, 122, 10.3389/fnagi.2019.00122

Akbari E, 2016, Effect of probiotic supplementation on cognitive function and metabolic status in Alzheimer's disease: a randomized, double-blind and controlled trial, Front Aging Neurosci, 8, 256, 10.3389/fnagi.2016.00256

Leblhuber F, 2018, Probiotic supplementation in patients with Alzheimer's dementia: an explorative intervention study, Curr Alzheimer Res, 15, 1106, 10.2174/1389200219666180813144834

Liu B, 2018, Efficacy of probiotics on anxiety-A meta-analysis of randomized controlled trials, Depress Anxiety, 35, 935, 10.1002/da.22811

Chong HX, 2019, Lactobacillus plantarum DR7 alleviates stress and anxiety in adults: a randomised, double-blind, placebo-controlled study, Benef Microbes, 10, 355, 10.3920/BM2018.0135

Stephen AM, 2017, Dietary fibre in Europe: current state of knowledge on definitions, sources, recommendations, intakes and relationships to health, Nutr Res Rev, 30, 149, 10.1017/S095442241700004X

Lefter R, 2019, A descriptive review on the prevalence of gastrointestinal disturbances and their multiple associations in autism spectrum disorder., Medicina (Kaunas), 56, E11, 10.3390/medicina56010011

Ristori MV, 2019, Autism, gastrointestinal symptoms and modulation of gut microbiota by nutritional interventions., Nutrients, 11, E2812, 10.3390/nu11112812

Alshammari MK, 2019, Incidence of Clostridium perfringens and its toxin genes in the gut of children with autism spectrum disorder, Anaerobe, 61, 102114, 10.1016/j.anaerobe.2019.102114

Buffington SA, 2016, Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring, Cell, 165, 1762, 10.1016/j.cell.2016.06.001

Evans SJ, 2017, The gut microbiome composition associates with bipolar disorder and illness severity, J Psychiatr Res, 87, 23, 10.1016/j.jpsychires.2016.12.007

Dickerson F, 2018, Adjunctive probiotic microorganisms to prevent rehospitalization in patients with acute mania: a randomized controlled trial, Bipolar Disord, 20, 614, 10.1111/bdi.12652

Benton D, 2007, Impact of consuming a milk drink containing a probiotic on mood and cognition, Eur J Clin Nutr, 61, 355, 10.1038/sj.ejcn.1602546

Akkasheh G, 2016, Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial, Nutrition, 32, 315, 10.1016/j.nut.2015.09.003

Miyaoka T, 2018, Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder: a prospective open-label trial, Clin Neuropharmacol, 41, 151, 10.1097/WNF.0000000000000299

Scheperjans F, 2015, Gut microbiota are related to Parkinson's disease and clinical phenotype, Mov Disord, 30, 350, 10.1002/mds.26069

Hasegawa S, 2015, Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease, PLoS One, 10, e0142164, 10.1371/journal.pone.0142164

Nguyen TT, 2019, Differences in gut microbiome composition between persons with chronic schizophrenia and healthy comparison subjects, Schizophr Res, 204, 23, 10.1016/j.schres.2018.09.014

Ghaderi A, 2019, Clinical and metabolic response to vitamin D plus probiotic in schizophrenia patients, BMC Psychiatry, 19, 77, 10.1186/s12888-019-2059-x

Okubo R, 2019, Effect of bifidobacterium breve A-1 on anxiety and depressive symptoms in schizophrenia: a proof-of-concept study, J Affect Disord, 245, 377, 10.1016/j.jad.2018.11.011

Zheng P, 2019, The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice., Sci Adv, 5, eaau8317, 10.1126/sciadv.aau8317